New pharmacologic targets for the treatment of the overactive bladder: An updateANDERSSON, Karl-Erik.Urology (Ridgewood, NJ). 2004, Vol 63, Num 3A, pp 32-41, issn 0090-4295, 10 p., SUPConference Paper

The medical management of refractory Overactive BladderROBINSON, Dudley; GIARENIS, Ilias; CARDOZO, Linda et al.Maturitas (Amsterdam). 2013, Vol 74, Num 4, pp 386-390, issn 0378-5122, 5 p.Article

Vessie hyperactive: optimiser l'utilisation et l'efficacité des anticholinergiquesPIGNE, Alain.Pelvi-périnéologie. 2009, Vol 4, Num 4, issn 1778-3712, S3-S5, SUP1Article

Detrusor overactivity: an updateTOOZS-HOBSON, P; ELNAQA, A.BJOG (Oxford. Print). 2004, Vol 111, pp 53-56, issn 1470-0328, 4 p., SUP1Conference Paper

Impact of Overactive Bladder on Work ProductivityCOYNE, Karin S; SEXTON, Chris C; THOMPSON, Christine L et al.Urology (Ridgewood, NJ). 2012, Vol 80, Num 1, pp 97-103, issn 0090-4295, 7 p.Article

Pathophysiology of overactive bladderCHU, Franklin M; DMOCHOWSKI, Roger.The American journal of medicine. 2006, Vol 119, Num 3A, issn 0002-9343, 3S-8S, SUPArticle

Overactive Bladder Is Not Only Overactive but Also HypersensitiveSEUNG RYEOL LEE; HYUNG JOON KIM; KIM, Ayoung et al.Urology (Ridgewood, NJ). 2010, Vol 75, Num 5, pp 1053-1059, issn 0090-4295, 7 p.Article

Diagnosing and treating overactive bladder: Special considerations for an aging population : MENOPAUSAL MEDICINEGUESS, Marsha K; CONNELL, Kathleen A.Sexuality, reproduction & menopause. 2009, Vol 7, Num 4, issn 1546-2501, S6-S12 [6 p.]Article

The urothelium in overactive bladder: Passive bystander or active participant?DE GROAT, William C.Urology (Ridgewood, NJ). 2004, Vol 64, Num 6A, pp 7-11, issn 0090-4295, 5 p., SUPConference Paper

Overactive Bladder and Continence Guidelines : implementation, inaction or frustration? CommentarySTASKIN, D. R; WAGG, A; MILSOM, I et al.International journal of clinical practice (Esher). 2008, Vol 62, Num 10, issn 1368-5031, 1466-1467, 1588-1593 [8 p.]Article

Overactive bladder and urinary incontinence : A multitherapy approach to treatmentWOOD, Kristine L; FOLKERTS, Debra; FINSTROM, Karen et al.Sexuality, reproduction & menopause. 2006, Vol 4, Num 2, pp 66-70, 5 p.Article

Principes d'action et indication de la toxine botulique dans le traitement de l'hyperactivité vésicale = Use and mechanism of botulinum toxin in overactive bladder treatmentGRISE, P; DAOUDI, Y; TANNEAU, Y et al.Annales d'urologie. 2005, Vol 39, Num 3-4, pp 105-115, issn 0003-4401, 11 p.Article

Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladderJUSZCZAK, Kajetan; ZIOMBER, Agata; WYCZOLKOWSKI, Marek et al.Canadian journal of physiology and pharmacology. 2010, Vol 88, Num 9, pp 899-906, issn 0008-4212, 8 p.Article

Responsiveness and Minimal Clinically Important Change in Overactive Bladder Symptom ScoreGOTOH, Momokazu; HOMMA, Yukio; YOKOYAMA, Osamu et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 4, pp 768-773, issn 0090-4295, 6 p.Article

Pharmacokinetics and Pharmacodynamics of Propiverine in Children Aged between 5 and 10 Years with Symptoms of Overactive BladderSIEGMUND, Werner; SILLEN, Ulla; LÄCKGREN, Göran et al.Clinical pharmacokinetics. 2010, Vol 49, Num 5, pp 335-342, issn 0312-5963, 8 p.Article

Vulnerable Elderly Patients and Overactive Bladder SyndromeKRAUS, Stephen R; BAVENDAM, Tamara; BRAKE, Tiffany et al.Drugs & aging. 2010, Vol 27, Num 9, pp 697-713, issn 1170-229X, 17 p.Article

Physiopathologie de l'hyperactivité vésicale = Pathophysiology of bladder overactivityKERDRAON, J; MANUNTA, A; COIGNARD, P et al.La Lettre de médecine physique et de réadaptation. 2010, Vol 26, Num 2, pp 69-73, issn 1778-4298, 5 p.Article

On the origins of the sensory output from the bladder : the concept of afferent noiseGILLESPIE, James I; VAN KOEVERINGE, Gommert A; DE WACHTER, Stefan G et al.BJU international (Papier). 2009, Vol 103, Num 10, pp 1324-1333, issn 1464-4096, 10 p.Article

Pathophysiology of Urinary Incontinence, Voiding Dysfunction, and Overactive BladderRAHN, David D; ROSHANRAVAN, Shayzreen M.Obstetrics and gynecology clinics of North America. 2009, Vol 36, Num 3, issn 0889-8545, x, 463-474 [13 p.]Article

AMTB, a TRPM8 channel blocker : evidence in rats for activity in overactive bladder and painful bladder syndromeLASHINGER, Erin S. R; STEIGINGA, Matthew S; HIEBLE, J. Paul et al.American journal of physiology. Renal physiology. 2008, Vol 64, Num 3, issn 1931-857X, F803-F810Article

Absorption, metabolism, and excretion of [¹⁴C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjectsOHMORI, Satoshi; MIURA, Masahiro; TORIUMI, Chifuyu et al.Drug metabolism and disposition. 2007, Vol 35, Num 9, pp 1624-1633, issn 0090-9556, 10 p.Article

Antimuscarinic agents : Implications and concerns in the management of overactive bladder in the elderlyKAY, Gary G; GRANVILLE, Lisa J.Clinical therapeutics. 2005, Vol 27, Num 1, pp 127-138, issn 0149-2918, 12 p.Article

Factors that distinguish continent from incontinent older adults with detrusor overactivityROSENBERG, Lisa J; GRIFFITHS, Derek J; RESNICK, Neil M et al.The Journal of urology. 2005, Vol 174, Num 5, pp 1868-1872, issn 0022-5347, 5 p.Article

Repeated botulinum-a toxin injections in treatment of children with neurogenic detrusor overactivity. CommentarySCHULTE-BAUKLOH, Heinrich; KNISPEL, Helmut H; STOLZE, Thomas et al.Urology (Ridgewood, NJ). 2005, Vol 66, Num 4, pp 865-870, issn 0090-4295, 6 p.Article

Post-void residual urine volume in women with overactive bladder symptomsMILLEMAN, Mark; LANGENSTROER, Peter; GURALNICK, Michael L et al.The Journal of urology. 2004, Vol 172, Num 5, pp 1911-1914, issn 0022-5347, 4 p., 1Article